HC Wainwright & Co. Maintains Buy on Apollomics, Lowers Price Target to $2
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Robert Burns has maintained a Buy rating on Apollomics (NASDAQ:APLM) but has lowered the price target from $5 to $2.
May 08, 2024 | 7:12 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Apollomics' price target was reduced from $5 to $2 by HC Wainwright & Co., although the Buy rating was maintained.
The reduction in price target by HC Wainwright & Co. suggests a downward revision in the expected performance or valuation of Apollomics, which could lead to short-term negative sentiment among investors. However, maintaining a Buy rating indicates a belief in the company's long-term potential.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100